The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of pancreatic enzyme replacement therapy (PERT) on overall survival (OS) in patients (pts) with advanced pancreatic ductal adenocarcinoma (APDAC) and evidence of pancreatic enzyme insufficiency (PEI): A single institution, retrospective, cohort study.
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Amgen; Cigna; Johnson & Johnson; McKesson; Thermo Fisher Scientific
Consulting or Advisory Role - TriSalus Life Sciences
Research Funding - Abbvie; FibroGen; Ipsen; NGM Biopharmaceuticals; NovoCure; Tyme
 
Anas Najjar
No Relationships to Disclose
 
Diala E Harb
Employment - Abbvie
Stock and Other Ownership Interests - ABBVIE/ABBOTT
 
Jens J Kort
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Meg T. Mandelson
No Relationships to Disclose